We learned much more about the role of circulating tumor DNA (ctDNA) tests in treating colorectal cancer at this meeting. I’m looking forward to Manju’s insights about that. From my end, I’d like to highlight four abstracts about The post GI ASCO Updates appeared first on Fight CRC ..read more

Fight Colorectal Cancer (Fight CRC) is thrilled to announce the successful conclusion of the 2024 summer fundraising season. Between the capstone Climb for a Cure event, along with several community fundraising events, the Fight CRC community raised more The post Summer Fundraisers Raise Over $165,000 appeared first on Fight CRC ..read more

In this blog, we take a deep dive into the Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations (NCT06412198) clinical trial alongside Drs. Christine Parseghian and Bennett The post Targeted therapy meets immunotherapy: a clinical trial for persons with metastatic KRAS G12C-mutant colorectal cancer appeared first on Fight CRC ..read more

Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization for colorectal cancer awareness, research, and policy, is proud to announce the promotion of Anjee Davis to Chief Executive Officer (CEO). This pivotal leadership change comes as The post Fight CRC Names Anjee Davis as CEO, Driving Bold Vision for the Future appeared first on Fight CRC ..read more

Fight Colorectal Cancer (Fight CRC) is proud to announce that its Genetics and Family History Advisory Council is leading an initiative, alongside nearly 150 patient advocacy organizations, medical societies, and medical professionals, to submit an application to the International Classification of Diseases (ICD-10) Coordination and Maintenance Committee to create a code specifically for Lynch syndrome. The post Early Career Award to Drive Lynch Syndrome Management appeared first on Fight CRC ..read more

Patients with microsatellite instability (MSI)/mismatch repair deficient (dMMR) colon cancer who undergo surgery may benefit from receiving neoadjuvant immunotherapy. Standard-of-care chemotherapy offers limited benefit to patients with MSI-H/dMMR colon cancer, with recurrence rates up to 40% in individuals The post ESMO Updates appeared first on Fight CRC ..read more

What an exciting month June has been so far! You relentlessly raised your voice alongside the GI community to object to UnitedHealthcare’s prior authorization policy. Advocates sent almost 1,200 action alerts, as well as countless tweets The post Advocacy wins and survivorship appeared first on Fight CRC ..read more

After many years of dedicated work and impactful contributions to the fight against cancer, the Matthew Hill Foundation is closing their doors and passing the razor to Fight Colorectal Cancer (Fight CRC). Fight CRC is excited to The post A New Era for No-Shave November appeared first on Fight CRC ..read more

Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization for colorectal cancer awareness, research, and policy, is proud to announce the promotion of Anjee Davis to Chief Executive Officer […] The post Fight CRC Names Anjee Davis as CEO, Driving Bold Vision for the Future appeared first on Fight Colorectal Cancer ..read more

Co-hosted by Exact Sciences and Fight Colorectal Cancer, the Summit Focuses on Collaboration and Actionable Solutions On October 7-9, 2024, Fight Colorectal Cancer co-hosted with the inaugural Innovation Summit with […] The post Innovation Summit Sparks Action for Advancing Colorectal Cancer Screening appeared first on Fight Colorectal Cancer ..read more